Posted inPress releases Alzheimer’s Association Encourages Americans to Take Charge of Their Brain Health by Alzheimer's Association June 3, 2024July 4, 2024
Posted inPress releases Exciting New Findings Highlight Summer Camps’ Role in the US Economy by American Camp Association June 3, 2024July 4, 2024
Posted inPress releases New Kearney report: Chemicals M&A rebound expected in the next 12 to 18 months with return of sustainability goals, predict more than 50% of industry execs by Kearney June 3, 2024July 4, 2024
Posted inPress releases ASHTON-DRAKE RELEASES PREMIUM “RUDOLPH THE RED-NOSED REINDEER®” MASTERPIECE FIGURE COLLECTION by The Bradford Exchange June 2, 2024July 4, 2024
Posted inPress releases 10 Fitness Guarantees Uninterrupted Gym Access with SARA, Even After Hours by 10 Fitness, LLC June 2, 2024July 4, 2024
Posted inPress releases MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer by MEDSIR June 2, 2024July 4, 2024
Posted inPress releases Tolmar Announces Results From Inaugural Landmark Survey of US Physicians To Assess Current State of Testosterone Replacement Therapy (TRT) and the Impact on Practices and Patient Care by TOLMAR Inc. June 2, 2024July 4, 2024
Posted inPress releases GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting by GenFleet Therapeutics June 1, 2024July 4, 2024
Posted inPress releases BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025 by STEMREGEN June 1, 2024July 4, 2024
Posted inPress releases Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting by Immunofoco June 1, 2024July 4, 2024
